Skip to main content
17 January 2021
Last updated:
Saturday 16 January 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
    • News
    • Appointments
    • Events
  • About MedNous
  • Research Directory
  • Contact Us

News - Appointments

Scancell makes two medical appointments

Sunday 29 November 2020
Company
Scancell Holdings Plc
Appointee Name
Gillies O'Bryan-Tear and 
Robert Miller

Scancell Holdings Plc, which is developing vaccines against cancer as well as Covid-19, has appointed Gillies O’Bryan-Tear as chief medical officer and Robert Miller as medical director.

Country

United Kingdom

  • Read more about Scancell makes two medical appointments

Suba Krishnan to join Mereo BioPharma

Sunday 29 November 2020
Company
Mereo BioPharma Group Plc
Appointee Name
Suba 
Krishnan

Suba Krishnan, an oncology expert, is to join Mereo BioPharma Group Plc on 7 December as head of clinical development where she will help advance etigilimab, a prospective treatment for advanced solid tumours.

Country

United Kingdom

  • Read more about Suba Krishnan to join Mereo BioPharma

Torsten Hoffmann joins Oryzon Genomics

Saturday 28 November 2020
Company
Oryzon Genomics SA
Appointee Name
Torsten 
Hoffmann

Torsten Hoffmann, inventor of the anti-emetic medicine Akynzeo, has been named chief scientific officer at Oryzon Genomics SA which is developing epigenetic-based therapeutics.

Country

Barcelona
Spain

  • Read more about Torsten Hoffmann joins Oryzon Genomics

Marie Wikström Lindholm takes new role at Silence Therapeutics

Saturday 28 November 2020
Company
Silence Therapeutics Plc
Appointee Name
Marie Wikström 
Lindholm

Silence Therapeutics Plc has promoted Marie Wikström Lindholm to it

Country

United Kingdom

  • Read more about Marie Wikström Lindholm takes new role at Silence Therapeutics

Mogrify expands scientific advisory board

Saturday 28 November 2020
Company
Mogrify Ltd
Appointee Name
Christine Mummery, Graziella Pellegrini and 
Giulo Cossu

Mogrify Ltd is expanding its scientific advisory board with the appointment of three academic experts in the field of cell therapy.

Country

United Kingdom

  • Read more about Mogrify expands scientific advisory board

Stephen Squinto to chair Genenta Science

Wednesday 25 November 2020
Company
Genenta Science Srl
Appointee Name
Stephen 
Squinto

Stephen Squinto, an executive partner at OrbiMed Advisors LLC, has joined Genenta Science Srl as chairman of the company’s board of directors. Based in Milan, Italy, Genenta is developing a gene therapy for cancer.

Country

MI
Italy

  • Read more about Stephen Squinto to chair Genenta Science

Mario Philips becomes CEO of Polyplus-transfection

Monday 9 November 2020
Company
Polyplus-transfection SA
Appointee Name
Mario 
Philips

France-based Polyplus-transfection SA has appointed Mario Philips as chief executive officer to lead its service business for the gene and cell therapy industry.

Country

France

  • Read more about Mario Philips becomes CEO of Polyplus-transfection

ExeVir Bio makes two appointments to board of directors

Monday 9 November 2020
Company
ExeVir Bio BV
Appointee Name
Michel Kazatchkine and 
Stef Heylen

Belgium-based ExeVir Bio BV has appointed Michel Kazatchkine and Stef Heylen to its board of directors. The company is developing nanobody therapies providing broad protection against viral infections, including a lead candidate targeting for coronaviruses.

Country

Belgium

  • Read more about ExeVir Bio makes two appointments to board of directors

Kim Kjoeller and Günter Ditzinger join UNION therapeutics

Monday 9 November 2020
Company
UNION therapeutics A/S
Appointee Name
Kim Kjoeller and 
Günter Ditzinger

Denmark-based UNION therapeutics A/S has appointed Kim Kjoeller as chief executive, effective 1 January 2021, and Günter Ditzinger as chief technology officer.

Country

Denmark

  • Read more about Kim Kjoeller and Günter Ditzinger join UNION therapeutics

Adaptate Biotherapeutics appoints Stewart Kay as chief business officer

Monday 9 November 2020
Company
Adaptate Biotherapeutics Ltd
Appointee Name
Stewart 
Kay

Stewart Kay has joined UK-based Adaptate Biotherapeutics Ltd in the new role of chief business officer (CBO).

Country

United Kingdom

  • Read more about Adaptate Biotherapeutics appoints Stewart Kay as chief business officer

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page next ›
  • Last page last »

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Klaas Zuideveld becomes CEO of Versameb
Saturday January 16 2021
MorphoSys appoints new CFO
Thursday January 7 2021
Sam Herbert becomes COO at Clinigen
Wednesday January 6 2021
Wolfgang Baiker becomes CEO at Adrenomed
Wednesday January 6 2021
Alligator Bioscience appoints new CMO
Tuesday December 29 2020

© 2021 Evernow Publishing Ltd. Powered by Drupal.